Journal Article Page
Jump to
European Urology
Volume 49, issue 5, pages 767-938, May 2006Corrigenda
Corrigendum to: “How Good do Current LHRH Agonists Control Testosterone? Can this be Improved with Eligard®?” [Eur Urol Suppl 4/8 (2005) 30–36]
Bertrand Tombal a 
, Richard Berges b 1.
Published online 15 April 2006, page 937
Full-Text PDF (102 KB) Create Platinum Slide Series Place a comment
Refers to article:
How Good do Current LHRH Agonists Control Testosterone? Can this be Improved with Eligard?
November 2005 (Vol. 4, Issue 8, pages 30 - 36)
In the article starting on page 30 there are some unfortunate errors. On page 31, right column, line 4, 5% should be replaced by 2%, and on p. 31, right column, line 6, 34% should be replaced by 38%.
Fig. 2 and caption to Fig. 2 should be as printed below.
00397-6/assets/gr2.jpg)
Fig. 2
About 2–17% of patients fail to achieve a testosterone level of 50 ng/dL [13–17].
The caption to Fig. 3 should read as follows:
About 13–38% of patients fail to achieve a testosterone level of 20 ng/dL [14,15,17,18].
Footnotes
a Service d’Urologie, Cliniques universitaires Saint Luc UCL, Hippokrateslaan 10, 1200 Sint Lambrechts-Woluwe, Belgium
b Pan-Klinik am Neumarkt, Zeppelin Straße 1, 50667 Cologne, Germany
Corresponding author. Tel. +32 2 764 55 40; Fax: +32 2 764 55 80.
1
Award pages
Copyright © 